Page last updated: 2024-09-03

y 27632 and Fuchs' Endothelial Dystrophy

y 27632 has been researched along with Fuchs' Endothelial Dystrophy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hamuro, J; Kinoshita, S; Koizumi, N; Nakagawa, H; Okumura, N; Ueno, M1
Kinoshita, S; Koizumi, N; Okumura, N; Ueno, M1

Reviews

1 review(s) available for y 27632 and Fuchs' Endothelial Dystrophy

ArticleYear
New therapeutic modality for corneal endothelial disease using Rho-associated kinase inhibitor eye drops.
    Cornea, 2014, Volume: 33 Suppl 11

    Topics: Amides; Animals; Cell Adhesion; Cell Proliferation; Corneal Edema; Endothelium, Corneal; Enzyme Inhibitors; Fuchs' Endothelial Dystrophy; Humans; Ophthalmic Solutions; Pilot Projects; Pyridines; rho-Associated Kinases

2014

Other Studies

1 other study(ies) available for y 27632 and Fuchs' Endothelial Dystrophy

ArticleYear
Rho-associated kinase inhibitor eye drop treatment as a possible medical treatment for Fuchs corneal dystrophy.
    Cornea, 2013, Volume: 32, Issue:8

    Topics: Amides; Enzyme Inhibitors; Fuchs' Endothelial Dystrophy; Humans; Male; Middle Aged; Ophthalmic Solutions; Pyridines; rho-Associated Kinases; Treatment Outcome

2013